Clin2
NCT05491434Possibly a fitRecruiting

Study of muscle loss in colon cancer patients

SarcopeniaPostoperative ComplicationsInfection;Post Surg Procedure

Part of Brain & nervous system, Cancer, Digestive system clinical trials.

This trial looks at muscle loss (called sarcopenia) in people with colon cancer to test an intervention that may help strength or recovery. If you’re age 70 or older and meet the cancer and health requirements, you may be able to take part.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
370 people
Ages
70 years and older
Study type
Interventional

Who can take part

  • Be at least 70 years old
  • Have colon cancer (colon adenocarcinoma), not rectal cancer
  • Have no other cancer spread at the same time (no synchronous metastasis)
  • Not need urgent surgery right now
  • Be able to do daily activities at a level doctors consider ok (ECOG 0 to 2)
  • Be able to sign consent and follow the study plan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07817758Recruiting
Sarcopenia and surgery outcomes in older gastrointestinal cancer patients

This trial looks at whether low muscle mass (sarcopenia) before surgery affects recovery for older adults with gastrointestinal cancer. It may help doctors personalize care and improve outcomes.

Van, Van
NCT06274268Recruiting
Sarcopenia and cancer treatment side effects study

This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.

Chambéry
NCT07466862Not yet recruiting
Nutrition and exercise program to reduce muscle loss in advanced cancer

This study tests whether personalized cooking and nutrition guidance plus a physical activity program can help reduce muscle loss in people with advanced cancer. It aims to improve strength and quality of life during chemotherapy.

Petah Tikva
NCT06868095Enrolling by invitation
Sarcopenia’s impact on early-onset colorectal cancer

This study looks at how muscle loss (sarcopenia) affects people diagnosed with colorectal cancer before age 50. It uses CT or MRI scans taken at diagnosis to measure muscle mass and see how it relates to treatment and outcomes.

NCT03998202Recruiting
Study of chemotherapy side effects in older colorectal cancer patients

This study looks at how chemotherapy and immunotherapy affect the body in older adults with colorectal cancer, especially early side effects. It may help researchers understand why some people lose strength and how to better predict and manage treatment toxicity.

Millville, Delaware
NCT07732101Not yet recruiting
Exercise program for breast cancer survivors with muscle loss

This study tests whether a structured exercise program can help breast cancer survivors who have lost muscle strength and mass (sarcopenia) rebuild their muscle and improve their physical function. Participation involves supervised or guided exercises designed to be safe for your condition.

Beijing, Beijing Municipality

Hear when a new Sarcopenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.